Vivos Therapeutics, Inc.
Ticker: 1716166
Board Meeting in 10 days
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
6.41
+24.5%-5.5%
Expenditure
10.31
+3.3%-10.5%
Net Profit
-1.95
+64.4%+63.9%
OPM %
-60.74%
+32.89pp+9.05pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingVVOS
20262Dec
Board Meeting
Annual Meeting of Stockholders to elect directors, vote on e…
SEC Filing ↗ Board MeetingVVOS
202631Jul
Board Meeting
CFO Transition — Bradford Amman resigned as CFO, and Roman F…
SEC Filing ↗